Covington Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3
Closed -$1K 1082
2022
Q1
$1K Sell
3
-44
-94% -$9.57K ﹤0.01% 1057
2021
Q4
$11K Buy
47
+44
+1,467% +$11.3K ﹤0.01% 766
2021
Q3
$1K Sell
3
-75
-96% -$24.6K ﹤0.01% 974
2021
Q2
$27K Sell
78
-3
-4% -$909 ﹤0.01% 629
2021
Q1
$23K Buy
81
+3
+4% +$809 ﹤0.01% 581
2020
Q4
$19K Hold
78
﹤0.01% 585
2020
Q3
$22K Hold
78
﹤0.01% 530
2020
Q2
$21K Hold
78
﹤0.01% 547
2020
Q1
$25K Sell
78
-42
-35% -$12.7K ﹤0.01% 498
2019
Q4
$36K Buy
120
+42
+54% +$11.7K ﹤0.01% 508
2019
Q3
$18K Sell
78
-75
-49% -$17.5K ﹤0.01% 578
2019
Q2
$36K Buy
153
+35
+30% +$8.08K ﹤0.01% 476
2019
Q1
$28K Sell
118
-20
-14% -$6.3K ﹤0.01% 489
2018
Q4
$42K Hold
138
﹤0.01% 446
2018
Q3
$49K Hold
138
﹤0.01% 423
2018
Q2
$40K Sell
138
-15
-10% -$4.22K ﹤0.01% 457
2018
Q1
$42K Hold
153
﹤0.01% 451
2017
Q4
$49K Sell
153
-86
-36% -$27.6K ﹤0.01% 455
2017
Q3
$75K Buy
+239
New +$70.8K 0.01% 381

Other funds holding BIIB

Covington Capital Management's BIIB Position: Q2 2022 in Review

Covington Capital Management sold out of Biogen (BIIB) in Q2 2022, closing a stake of 3 shares — an estimated $1K sold.

Covington Capital Management first reported a position in BIIB in Q3 2017 and held it in 19 quarters. The position peaked at $75K in Q3 2017. 928 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.

  • Covington Capital Management reported no remaining Biogen position as of Q2 2022 after selling out during the quarter.
  • Covington Capital Management sold 3 Biogen shares in Q2 2022, an estimated $1K.
  • Covington Capital Management first reported a position in Biogen in Q3 2017 and held it in 19 quarters.
  • Covington Capital Management's Biogen position peaked at $75K in Q3 2017.
  • 928 funds tracked by Wall St. Rank held Biogen as of Q2 2022.

Based on Covington Capital Management's 13F filing for Q2 2022, filed 8 Jul 2022.